NEWS

NEWS 2023.5.29 Rebirthel signs collaborative research agreement  for the development of automated cell mass culture technology  to spread allogenic T cell therapy

Rebirthel Co., Ltd. (Rebirthel) announced that it entered into a collaboration research agreeme...

NEWS 2022.12.9 Mr. Masunori Kajikawa won the JVCA encouragement award of the 22nd Japan Venture Award.

The 22nd Japan venture Award (JVA) awards ceremony was held on December 8th, 2022. Mr. Masunori...

NEWS 2022.10.14 Japan Healthcare Venture Summit 2022

Rebirthel participated in the exhibition “Japan Healthcare Venture Summit 2022 (JHVS2022)”, hos...

NEWS 2022.9.26 Sogyo Techo, a media for entrepreneurs, featured an interview article of Mr. Masunori Kajikawa, President of Rebirthel.

“Sogyo Techo” is a free distribution medium targeting entrepreneurs. It makes15,000 printed cop...

NEWS 2022.9.23 Rebirthel will be exhibiting at Japan Healthcare
Venture Summit 2022

“Japan Healthcare Venture Summit 2022”, hosted by the Ministry of Health, Labourand Welfare, Ja...

NEWS 2022.9.1 Informa Pharma Intelligence Awards 2022

Informa Pharma Intelligence is the Japanese version of Scrips Awards, a worldwide-known award t...

NEWS 2022.7.5 Rebirthel won the JETRO award at the 7th HVC (Healthcare Venture Conference) KYOTO 2022.

HVC Kyoto, Japan’s largest English-spoken pitch event specializing in health care, was held on ...